Geert Robaeys

5.2k total citations
94 papers, 2.1k citations indexed

About

Geert Robaeys is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Geert Robaeys has authored 94 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Hepatology, 62 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Geert Robaeys's work include Hepatitis C virus research (70 papers), Hepatitis B Virus Studies (42 papers) and Liver Disease Diagnosis and Treatment (42 papers). Geert Robaeys is often cited by papers focused on Hepatitis C virus research (70 papers), Hepatitis B Virus Studies (42 papers) and Liver Disease Diagnosis and Treatment (42 papers). Geert Robaeys collaborates with scholars based in Belgium, Netherlands and Germany. Geert Robaeys's co-authors include Ger H. Koek, Marieke Wichers, Michaël Maes, Simon Scharpé, Robert Verkerk, Rob Bielen, Dana Busschots, Frederik Nevens, Frank Buntinx and Günter Kenis and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Geert Robaeys

89 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geert Robaeys Belgium 22 1.2k 1.2k 558 398 238 94 2.1k
Martin Schaefer Germany 25 1.0k 0.9× 1.1k 0.9× 401 0.7× 216 0.5× 468 2.0× 71 2.3k
Michael R. Kraus Germany 22 753 0.6× 770 0.6× 269 0.5× 157 0.4× 225 0.9× 53 1.6k
Daniel Forton United Kingdom 22 1.5k 1.2× 1.7k 1.4× 247 0.4× 90 0.2× 261 1.1× 53 2.4k
Eric Dieperink United States 22 1.2k 1.0× 1.2k 1.0× 218 0.4× 117 0.3× 191 0.8× 36 1.7k
Andrey Borisov United States 14 1.0k 0.8× 266 0.2× 551 1.0× 413 1.0× 205 0.9× 25 2.1k
Jeremy Tibble United Kingdom 13 683 0.6× 76 0.1× 143 0.3× 109 0.3× 62 0.3× 35 1.6k
Bruce H. Phelps United States 21 766 0.6× 638 0.5× 87 0.2× 15 0.0× 277 1.2× 42 1.7k
Ion Rogoveanu Romania 19 331 0.3× 266 0.2× 53 0.1× 39 0.1× 60 0.3× 122 1.1k
Brigida Barberio Italy 25 630 0.5× 74 0.1× 108 0.2× 37 0.1× 97 0.4× 111 2.8k
Janet L. Cunningham Sweden 25 398 0.3× 30 0.0× 205 0.4× 94 0.2× 133 0.6× 82 1.8k

Countries citing papers authored by Geert Robaeys

Since Specialization
Citations

This map shows the geographic impact of Geert Robaeys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Robaeys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Robaeys more than expected).

Fields of papers citing papers by Geert Robaeys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Robaeys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Robaeys. The network helps show where Geert Robaeys may publish in the future.

Co-authorship network of co-authors of Geert Robaeys

This figure shows the co-authorship network connecting the top 25 collaborators of Geert Robaeys. A scholar is included among the top collaborators of Geert Robaeys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geert Robaeys. Geert Robaeys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steenkiste, Christophe Van, et al.. (2025). Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The Netherlands. Biomedicines. 13(11). 2821–2821.
2.
Dagnelie, Pieter C., Casper G. Schalkwijk, Coen D.A. Stehouwer, et al.. (2024). Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study. BMJ Open Gastroenterology. 11(1). e001466–e001466. 2 indexed citations
3.
4.
Busschots, Dana, Rob Bielen, Özgür M. Koc, et al.. (2021). On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era. BMC Public Health. 21(1). 1574–1574. 3 indexed citations
5.
Busschots, Dana, et al.. (2021). Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine. 8. 615978–615978. 141 indexed citations
6.
Busschots, Dana, Cécile Kremer, Rob Bielen, et al.. (2021). A multicentre interventional study to assess blood-borne viral infections in Belgian prisons. BMC Infectious Diseases. 21(1). 708–708. 11 indexed citations
7.
Bielen, Rob, Özgür M. Koc, Dana Busschots, et al.. (2019). Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based study. BMJ Open. 9(5). e026464–e026464. 11 indexed citations
8.
Bielen, Rob, Christophe Moreno, Hans Van Vlierberghe, et al.. (2017). Belgian experience with direct acting antivirals in people who inject drugs. Drug and Alcohol Dependence. 177. 214–220. 19 indexed citations
9.
Bielen, Rob, et al.. (2016). Case Management to Improve Uptake for Screening and Therapy of Hepatitis C viral infection in People Who Inject Drugs. Document Server@UHasselt (UHasselt). 3 indexed citations
10.
Grebely, Jason, Geert Robaeys, Philip Bruggmann, et al.. (2015). Recommendations for the management of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy. 26(10). 1028–1038. 135 indexed citations
11.
Robaeys, Geert, Jason Grebely, Stefan Mauss, et al.. (2013). Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Clinical Infectious Diseases. 57(suppl 2). S129–S137. 86 indexed citations
12.
Nevens, Frederik, Isabelle Colle, P. Michielsen, et al.. (2012). Resource use and cost of hepatitis C-related care. European Journal of Gastroenterology & Hepatology. 24(10). 1191–1198. 21 indexed citations
13.
Bourgeois, Sharon, Ward Schrooten, & Geert Robaeys. (2010). 245 HIGH VIRAL RESPONSE IN A MULTIDISCIPLINARY NETWORK NOT ORGANIZED UNDER ONE ROOF FOR ANTIVIRAL MANAGEMENT OF CHRONIC HEPATITIS C VIRAL PATIENTS INFECTED AFTER SUBSTANCE USE. Journal of Hepatology. 52. S103–S104. 1 indexed citations
14.
Kenis, Günter, Jos Prickaerts, Jim van Os, et al.. (2010). Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?. The International Journal of Neuropsychopharmacology. 14(2). 247–253. 46 indexed citations
15.
Bourgeois, Nadine, Frederik Nevens, Jean Henrion, et al.. (2007). Daily induction combination treatment with alfa2b interferon or standard combination treatment in naive chronic hepatitis C patients. A controlled multicenter randomized trail.. Open Repository and Bibliography (University of Liège).
16.
Robaeys, Geert. (2007). An extremely rare case of delusional parasitosis in a chronic hepatitis C patient during pegylated interferon alpha-2b and ribavirin treatment. World Journal of Gastroenterology. 13(16). 2379–2379. 9 indexed citations
17.
Robaeys, Geert, et al.. (2005). The epidemiology of hepatitis C among injecting drug users in Belgium.. PubMed. 68(1). 50–4. 5 indexed citations
18.
Thoelen, Inge, Jannick Verbeeck, Elke Wollants, et al.. (2005). Frequency of the CCR5-Δ32 Mutant Allele Is Not Increased in Belgian Hepatitis C Virus-Infected Patients. Viral Immunology. 18(1). 232–235. 6 indexed citations
19.
Delwaide, Jean, Nadine Bourgeois, Christiane Gérard, et al.. (2004). Treatment of acute hepatitis C with interferon α‐2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Alimentary Pharmacology & Therapeutics. 20(1). 15–22. 46 indexed citations
20.
Robaeys, Geert, et al.. (2002). Management of hepatitis C virus infections in intravenous drug users.. PubMed. 65(2). 99–100. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Schaefer Breakdown of academic impact, for papers by Michael R. Kraus Breakdown of academic impact, for papers by Daniel Forton Breakdown of academic impact, for papers by Eric Dieperink Breakdown of academic impact, for papers by Andrey Borisov Breakdown of academic impact, for papers by Jeremy Tibble Breakdown of academic impact, for papers by Bruce H. Phelps Breakdown of academic impact, for papers by Ion Rogoveanu Breakdown of academic impact, for papers by Brigida Barberio Breakdown of academic impact, for papers by Janet L. Cunningham
Rankless by CCL
2026